Patents by Inventor SEVGI GÖKCEK

SEVGI GÖKCEK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical combinations of dabigatran and proton pump inhibitors
    Patent number: 10130618
    Abstract: This invention is a novel pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof in combination with a proton pump inhibitor for use in the antithrombotic treatment with preventing or reducing the risk of a gastrointestinal disorder.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: November 20, 2018
    Assignee: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Ali Türkyilmaz, Mehtap Saydam, Yildiz Gülkok, Nur Kirat Uzunogullari, Sevgi Gökcek
  • A NOVEL PHARMACEUTICAL COMPOSITION OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170151272
    Abstract: This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin as active agents with at least one pharmaceutically acceptable excipient, wherein at least one of the active agents is in the form of controlled release, for use in the treatment of hepatitis C virus infections, chronic hepatitis C, hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: June 1, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170128482
    Abstract: This invention is a novel modified release pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the treatment of hepatitis C virus infections, chronic hepatitis C (CHC), hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: May 11, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • PHARMACEUTICAL COMBINATIONS OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170112867
    Abstract: This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the treatment of hepatitis C virus infections, chronic hepatitis C (CHC), hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: April 27, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • PHARMACEUTICAL COMBINATIONS OF DABIGATRAN AND PROTON PUMP INHIBITORS
    Publication number: 20170035745
    Abstract: This invention is a novel pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof in combination with a proton pump inhibitor for use in the antithrombotic treatment with preventing or reducing the risk of a gastrointestinal disorder.
    Type: Application
    Filed: April 9, 2015
    Publication date: February 9, 2017
    Inventors: ALI TÜRKYILMAZ, MEHTAP SAYDAM, YILDIZ GÜLKOK, NUR KIRAT UZUNOGULLARI, SEVGI GÖKCEK